Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersHematology & Oncology Physician in Boston, MA
NPI: 1558309849Primary Practice Location
BETH ISRAEL DEACONESS MEDICAL CENTER
330 Brookline Ave, Boston, MA
Primary Employer
Harvard Medical Faculty Phys at Beth Israel Deaconess
hmfphysicians.org
HQ Phone
Get M.D. Kenneth's Phone Numberphone_androidMobile
Get M.D. Kenneth's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMA State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 83 | 109 |
| 2 | 99205New patient office or other outpatient visit, typically 60 minutes | 57 | 57 |
| 3 | 99223Initial hospital inpatient care, typically 70 minutes per day | 49 | 49 |
| 4 | 99215Established patient office or other outpatient, visit typically 40 minutes | 30 | 30 |
| 5 | 99213Established patient office or other outpatient visit, typically 15 minutes | 27 | 44 |
Authors: Mary Cushman, Neil Zakai
Journal: Blood Adv
Authors: Efstathios Papavassiliou, Daniel Kramer, Sara Ramel
Journal: Neonatal Netw
Prediction and prevention of thromboembolic events with enoxaparin in cancer patients with elevated tissue factor-bearing microparticles: a randomized-controlled phase II trial (the Microtec study).
Authors: Craig Kessler, Bruce Furie, Simon Mantha, Jeffrey Zwicker, Rachel Rosovsky, Jonathan Eneman
Publication Date: 2012-09-06
Lead Sponsor: Washington University School of Medicine
Collaborators: National Heart, Lung, and Blood Institute (NHLBI)
Intervention / Treatment: BIOLOGICAL: rituximab
Lead Sponsor: Jeffrey Zwicker, MD
Collaborators: National Heart, Lung, and Blood Institute (NHLBI), Quercegen Pharmaceuticals
Intervention / Treatment: DRUG: Isoquercetin
